These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 14525787)

  • 1. In vitro and in vivo evidence of PNH cell sensitivity to immune attack after nonmyeloablative allogeneic hematopoietic cell transplantation.
    Takahashi Y; McCoy JP; Carvallo C; Rivera C; Igarashi T; Srinivasan R; Young NS; Childs RW
    Blood; 2004 Feb; 103(4):1383-90. PubMed ID: 14525787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of paroxysmal nocturnal hemoglobinuria clonal dominance: possible roles of different apoptosis and CD8+ lymphocytes in the selection of paroxysmal nocturnal hemoglobinuria clones.
    Kunyaboon R; Wanachiwanawin W; U-Pratya Y; Thedsawad A; Taka O
    Hematol Oncol Stem Cell Ther; 2012; 5(3):138-45. PubMed ID: 23095789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cells expressing the activating NK-cell receptors KIR2DS4, NKG2C and NKG2D are elevated in paroxysmal nocturnal hemoglobinuria and cytotoxic toward hematopoietic progenitor cell lines.
    van Bijnen ST; Withaar M; Preijers F; van der Meer A; de Witte T; Muus P; Dolstra H
    Exp Hematol; 2011 Jul; 39(7):751-62.e1-3. PubMed ID: 21554925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosylphosphatidylinositol-specific, CD1d-restricted T cells in paroxysmal nocturnal hemoglobinuria.
    Gargiulo L; Papaioannou M; Sica M; Talini G; Chaidos A; Richichi B; Nikolaev AV; Nativi C; Layton M; de la Fuente J; Roberts I; Luzzatto L; Notaro R; Karadimitris A
    Blood; 2013 Apr; 121(14):2753-61. PubMed ID: 23372165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case report: Immune pressure on hematopoietic stem cells can drastically expand glycosylphosphatidylinositol-deficient clones in paroxysmal nocturnal hemoglobinuria.
    Shingai N; Mizumaki H; Najima Y; Yamada Y; Tran DC; Haraguchi K; Toya T; Okuyama Y; Doki N; Nannya Y; Ogawa S; Nakao S
    Front Immunol; 2023; 14():1329403. PubMed ID: 38288112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paroxysmal nocturnal hemoglobinuria with copy number-neutral 6pLOH in GPI (+) but not in GPI (-) granulocytes.
    Ueda Y; Nishimura J; Murakami Y; Kajigaya S; Kinoshita T; Kanakura Y; Young NS
    Eur J Haematol; 2014; 92(5):450-3. PubMed ID: 24931618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly homologous T-cell receptor beta sequences support a common target for autoreactive T cells in most patients with paroxysmal nocturnal hemoglobinuria.
    Gargiulo L; Lastraioli S; Cerruti G; Serra M; Loiacono F; Zupo S; Luzzatto L; Notaro R
    Blood; 2007 Jun; 109(11):5036-42. PubMed ID: 17284529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria in the Age of Eculizumab.
    Cooper JP; Farah RJ; Stevenson PA; Gooley TA; Storb R; Scott BL
    Biol Blood Marrow Transplant; 2019 Jul; 25(7):1331-1339. PubMed ID: 30711779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective TCR signaling events in glycosylphosphatidylinositol-deficient T cells derived from paroxysmal nocturnal hemoglobinuria patients.
    Romagnoli P; Bron C
    Int Immunol; 1999 Sep; 11(9):1411-22. PubMed ID: 10464162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inefficient response of T lymphocytes to glycosylphosphatidylinositol anchor-negative cells: implications for paroxysmal nocturnal hemoglobinuria.
    Murakami Y; Kosaka H; Maeda Y; Nishimura J; Inoue N; Ohishi K; Okabe M; Takeda J; Kinoshita T
    Blood; 2002 Dec; 100(12):4116-22. PubMed ID: 12393537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic stem cell transplantation with alpha/beta T-lymphocyte depletion and short course of eculizumab in adolescents and young adults with paroxysmal nocturnal hemoglobinuria.
    Shasheleva DA; Maschan AA; Shelikhova LN; Petrova UN; Kurnikova EE; Illarionova OI; Boyakova EV; Novichkova GA; Maschan MA
    Ter Arkh; 2018 Aug; 90(7):57-64. PubMed ID: 30701923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of fludarabine-based reduced-intensity allogeneic hematopoietic cell transplantation for debilitating paroxysmal nocturnal hemoglobinuria.
    Pantin J; Tian X; Geller N; Ramos C; Cook L; Cho E; Scheinberg P; Vasu S; Khuu H; Stroncek D; Barrett J; Young NS; Donohue T; Childs RW
    Biol Blood Marrow Transplant; 2014 Sep; 20(9):1435-9. PubMed ID: 24844857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic and functional analysis of lymphocytes in paroxysmal nocturnal hemoglobinuria.
    Tseng JE; Hall SE; Howard TA; Ware RE
    Am J Hematol; 1995 Dec; 50(4):244-53. PubMed ID: 7485098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic hematopoietic cell transplantation for paroxysmal nocturnal hemoglobinuria.
    Lee JL; Lee JH; Lee JH; Choi SJ; Kim S; Seol M; Lee YS; Chi HS; Park CJ; Kim WK; Lee JS; Lee KH
    Eur J Haematol; 2003 Aug; 71(2):114-8. PubMed ID: 12890150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cells from paroxysmal nocturnal haemoglobinuria (PNH) patients show an altered CD40-dependent pathway.
    Terrazzano G; Sica M; Becchimanzi C; Costantini S; Rotoli B; Zappacosta S; Alfinito F; Ruggiero G
    J Leukoc Biol; 2005 Jul; 78(1):27-36. PubMed ID: 15817705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoselection by natural killer cells of PIGA mutant cells missing stress-inducible ULBP.
    Hanaoka N; Kawaguchi T; Horikawa K; Nagakura S; Mitsuya H; Nakakuma H
    Blood; 2006 Feb; 107(3):1184-91. PubMed ID: 16195329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential expression of human Fc gamma RIIIPMN (CD16) in paroxysmal nocturnal hemoglobinuria. Discordant expression of glycosyl phosphatidylinositol-linked proteins.
    Edberg JC; Salmon JE; Whitlow M; Kimberly RP
    J Clin Invest; 1991 Jan; 87(1):58-67. PubMed ID: 1702101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quantity and function of T cell subsets in patients with paroxysmal nocturnal hemoglobinuria].
    Zhang T; Liang Y; Fu R; Li LJ; Wang J; Liu H; Wang HL; Ruan EB; Qu W; Wang GJ; Wu YH; Liu H; Wang HQ; Wang XM; Song J; Guan J; Xing LM; Shao ZH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):721-5. PubMed ID: 20561437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Paroxysmal nocturnal hemoglobinuria (PNH). Pathogenesis, diagnosis and treatment].
    Röth A; Dührsen U; Schrezenmeier H; Schubert J
    Dtsch Med Wochenschr; 2009 Feb; 134(9):404-9. PubMed ID: 19224425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycosylphosphatidylinositol-anchored protein deficiency confers resistance to apoptosis in PNH.
    Savage WJ; Barber JP; Mukhina GL; Hu R; Chen G; Matsui W; Thoburn C; Hess AD; Cheng L; Jones RJ; Brodsky RA
    Exp Hematol; 2009 Jan; 37(1):42-51. PubMed ID: 19013003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.